Esophageal Adenocarcinoma Methods and Protocols

(sharon) #1

76



  1. Karaoglanoglu N, Eroglu A, Turkyilmaz A,
    Gursan N (2005) Esophageal adenoid cystic
    carcinoma and its management options. Int
    J Clin Pract 59:1101–1103

  2. Petursson SR (1986) Adenoid cystic carcinoma
    of the esophagus: complete response to combi-
    nation chemotherapy. Cancer 57:1464–1467

  3. Zhou Y, Zang Y, Xiang J, Tang F, Chen Z
    (2014) Adenoid cystic carcinoma of the cardia:
    report of a rare case and review of the Chinese
    literature. Oncol Lett 8:726–730

  4. Guo XF, Mao T, Gu ZT, Fang WT, Chen WH,
    Shao JC (2012) Adenoid cystic carcinoma of
    the esophagus: report of two cases and review
    of the Chinese literature. Diagn Pathol 7:179

  5. Sawada G, Moon J, Saito A, Odagiri K, Kimura
    Y, Takahashi G, Yamashita S, Inoue M, Irei T,
    Nakahira S, Shimizu Y, Tominaga H, Kuraoka
    K, Taniyama K, Hatanaka N (2015) A case of
    adenoid cystic carcinoma of the esophagus.
    Surg Case Rep 1:119

  6. Fegelman E, Law SY, Fok M, Lam KY, Loke
    SL, Ma LT, Wong J (1994) Squamous cell car-
    cinoma of the esophagus with mucin-secreting
    component: mucoepidermoid carcinoma.
    J Thorac Cardiovasc Surg 107:62–67

  7. Lam KY, Loke SL, Ma LT (1993)
    Histochemistry of mucin secreting compo-
    nents in mucoepidermoid and adenosquamous
    carcinoma of the esophagus. J Clin Pathol
    46:1011–1015

  8. Lam KY, Dickens P, Loke SL, Fok M, Ma L,
    Wong J (1994) Squamous cell carcinoma of the
    esophagus with mucin-secreting component
    (muco-epidermoid carcinoma and adenosqua-
    mous carcinoma): a clinicopathologic study
    and a review of literature. Eur J Surg Oncol
    20:25–31

  9. Chen S, Chen Y, Yang J, Yang W, Weng H, Li
    H, Liu D (2011) Primary mucoepidermoid
    carcinoma of the esophagus. J Thorac Oncol
    6:1426–1431

  10. Ni PZ, Yang YS, Hu WP, Wang WP, Yuan Y,
    Chen LQ (2016) Primary adenosquamous car-
    cinoma of the esophagus: an analysis of 39
    cases. J Thorac Dis 8:2689–2696

  11. van der Kaaij RT, Snaebjornsson P, Voncken
    FE, van Dieren JM, Jansen EP, Sikorska K,
    Cats A, van Sandick JW (2017) The prognostic
    and potentially predictive value of the Laurén
    classification in esophageal adenocarcinoma.
    Eur J Cancer 76:27–35
    18. Chirieac LR, Swisher SG, Correa AM, Ajani
    JA, Komaki RR, Rashid A, Hamilton SR, Wu
    TT (2005) Signet-ring cell or mucinous histol-
    ogy after preoperative chemoradiation and sur-
    vival in patients with esophageal or
    esophagogastric junction adenocarcinoma.
    Clin Cancer Res 11:2229–2236
    19. Turner KO, Genta RM, Sonnenberg A (2015)
    Esophageal signet ring cell carcinoma as com-
    plication of gastro-esophageal reflux disease.
    Aliment Pharmacol Ther 42:1222–1231
    20. Piessen G, Messager M, Lefevre JH, Goéré D,
    Mabrut JY, Meunier B, Brigand C, Hamy A,
    Glehen O, Mariette C, FREGAT Working
    Group—FRENCH (2014) Signet ring cell
    adenocarcinomas: different clinical-
    pathological characteristics of esophageal and
    gastric locations. Eur J Surg Oncol
    40:1746–1755
    21. Enlow JM, Denlinger CE, Stroud MR, Ralston
    JS, Reed CE (2013) Adenocarcinoma of the
    esophagus with signet ring cell features por-
    tends a poor prognosis. Ann Thorac Surg
    96:1927–1932
    22. Nafteux PR, Lerut TE, Villeneuve PJ,
    Dhaenens JM, De Hertogh G, Moons J,
    Coosemans WJ, Van Veer HG, De Leyn PR
    (2014) Signet ring cells in esophageal and gas-
    tresophageal junction carcinomas have a more
    aggressive biological behavior. Ann Surg
    260:1023–1029
    23. Chen L, Liu X, Gao L, Wang R, Gao D, Bai D
    (2017) The clinicopathological features and
    prognosis of signet ring cell carcinoma of the
    esophagus: a 10-year retrospective study in
    China. PLoS One 12:e0176637
    24. Thies S, Langer R (2013) Tumor regression
    grading of gastrointestinal carcinomas after
    neoadjuvant treatment. Front Oncol 3:262
    25. Noble F, Nolan L, Bateman AC, Byrne JP, Kelly
    JJ, Bailey IS, Sharland DM, Rees CN, Iveson
    TJ, Underwood TJ, Bateman AR (2013)
    Refining pathological evaluation of neoadjuvant
    therapy for adenocarcinoma of the esophagus.
    World J Gastroenterol 19:9282–9293
    26. Karamitopoulou E, Thies S, Zlobec I, Ott K,
    Feith M, Slotta-Huspenina J, Lordick F, Becker
    K, Langer R (2014) Assessment of tumor
    regression of esophageal adenocarcinomas after
    neoadjuvant chemotherapy: comparison of 2
    commonly used scoring approaches. Am J Surg
    Pathol 38:1551–1556


Alfred K. Lam
Free download pdf